NL-OMON27994尚未招募不适用
Antiviral therapy (cidofovir, an acyclic nucleoside phosphate) in combination with radiotherapy in HPV-positive tumors of the oropharynx
initiator = sponsor0 个研究点目标入组 12 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Histological proven HPV-positive carcinoma of the oropharynx in the dose escalating schedule.
- •2. UICC TNM I-IV, for which curable (high dosing) radiotherapy is advised.
排除标准
- •1. More then 10% weight loss the last 6 months.
- •2. Abnormal serum bilirubin, white blood cells, neutrophils, platelets, hemoglobin.
研究者
相似试验
已完成
不适用
Antiviral therapy (cidofovir, an acyclic nucleoside phosphate) in combination with radiotherapy in HPV-positive tumours of the oropharynx: a phase 1 study.NL-OMON33865Academisch Ziekenhuis Maastricht12
招募中
不适用
Antiviral therapy with direct acting anti-virals in hepatitis C patients.Chronic hepatitis CJPRN-UMIN000016288Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine500
招募中
1 期
Contribution of an antiviral drug (Valaciclovir) in the treatment of generalized periodontitis (stage III or IV and grade A, B or C)Generalized periodontitis (stage III or IV and grade A, B or C)CTIS2022-501957-35-00Centre Hospitalier Universitaire De Nice142
招募中
不适用
Antiviral therapy for HCV using direct acting antiviral drugs in patients with chronic hepatitis C undergoing hemodialysis.Patients with HCV genotype 1B infection who are undergoing maintenance hemodialysis.JPRN-UMIN000017023Ogaki Municipal Hospital150
已完成
不适用
Highly active anti-retroviral therapy including nevirapine once daily versus twice daily after at least 12 weeks of nevirapine twice daily. A randomized, open, multicentre trial.ISRCTN81305260Institute of Biomedical Investigations of Bellvitge (Institut d'Investigació Biomèdica de Bellvitge) (IDIBELL) (Spain)308